Phase 3 Trial Results Look Promising for Rheumatoid Arthritis Treatment Sarilumab

Phase 3 Trial Results Look Promising for Rheumatoid Arthritis Treatment Sarilumab

“Despite the availability of a wide range of treatment options, we believe that new therapies are needed to further address unmet needs of rheumatoid arthritis patients,” said Dr. Simon Cooper, MBBS vice president and global project head of immunology

(Visited 3 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.